Jensen Investment Management G trades
Eric H. Schoenstein
Eric H. Schoenstein GENPACT LTD stake
total: 257
Trades details
- Total transactions:
- 13
- New positions:
- 1
- Added:
- 8
- Reduced:
- 4
- Held since:
- 2022 Q2
- Held for:
- 17 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Eric H. Schoenstein holds 73,655 GENPACT LTD (G) shares with a market value of roughly $2.03M accounting for 0.05% of the overall portfolio. To date, the estimated cost basis is nearly $39.88 for "buy" trades and estimated average "sell" price is $42.36. Jensen Investment Management first purchased G in 2022 Q2, initially acquiring 106,380 shares. Since the initial investment in GENPACT LTD (G), Jensen Investment Management has made 12 more transactions.
When did Eric H. Schoenstein buy GENPACT LTD (G)?
Eric H. Schoenstein first invested in GENPACT LTD (G) in 2022 Q2 at the reported quarter-end price of $42.36 per share.
What's the cost basis of Jensen Investment Management's G stake?
The estimated cost basis for GENPACT LTD (G) stake is around $39.88 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $39.88
- Weighted AVG sell price:
- $42.36
Eric H. Schoenstein's historical trades in GENPACT LTD
13 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
0.05%
|
73,655
|
$27.50
|
$2,025,513
|
-20.79% (-19,330)
|
-0.01%
|
|
2026 Q1
|
0.07%
|
92,985
|
$37.25
|
$3,463,691
|
-20.27% (-23,640)
|
-0.01%
|
|
2025 Q3
|
0.06%
|
116,625
|
$41.89
|
$4,885,421
|
-21.30% (-31,570)
|
-0.02%
|
|
2025 Q2
|
0.08%
|
148,195
|
$44.01
|
$6,522,062
|
+3.83% (+5,460)
|
+0%
|
|
2025 Q1
|
0.08%
|
142,735
|
$50.38
|
$7,190,989
|
-26.98% (-52,750)
|
-0.02%
|
|
2024 Q4
|
0.08%
|
195,485
|
$42.95
|
$8,396,081
|
+2.89% (+5,500)
|
+0%
|
|
2024 Q3
|
0.06%
|
189,985
|
$39.21
|
$7,449,312
|
+6.39% (+11,410)
|
+0%
|
|
2024 Q1
|
0.04%
|
178,575
|
$32.95
|
$5,884,046
|
+16.66% (+25,505)
|
+0.01%
|
|
2023 Q4
|
0.04%
|
153,070
|
$34.71
|
$5,313,060
|
+5.14% (+7,480)
|
+0%
|
|
2023 Q3
|
0.04%
|
145,590
|
$36.20
|
$5,270,358
|
+12.42% (+16,080)
|
+0%
|
|
2023 Q2
|
0.04%
|
$37.57
|
+17.29% (+19,090)
|
|||
|
2023 Q1
|
0.04%
|
$45.52
|
+3.80% (+4,040)
|
|||
|
2022 Q2
|
0.04%
|
$42.36
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.